Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A microRNA signature for the differential diagnosis of salivary gland tumors.

Denaro M, Navari E, Ugolini C, Seccia V, Donati V, Casani AP, Basolo F.

PLoS One. 2019 Jan 25;14(1):e0210968. doi: 10.1371/journal.pone.0210968. eCollection 2019.

2.

Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study.

Cinpolat O, Unal ZN, Ismi O, Gorur A, Unal M.

Braz J Otorhinolaryngol. 2017 May - Jun;83(3):276-284. doi: 10.1016/j.bjorl.2016.03.013. Epub 2016 Apr 27.

3.

Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors.

Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JG, Veerman EC, Bloemena E, Wong DT.

Clin Cancer Res. 2013 Jun 1;19(11):3032-8. doi: 10.1158/1078-0432.CCR-12-3505. Epub 2013 Apr 10.

4.

MicroRNA profiling in intraocular medulloepitheliomas.

Edward DP, Alkatan H, Rafiq Q, Eberhart C, Al Mesfer S, Ghazi N, Al Safieh L, Kondkar AA, Abu Amero KK.

PLoS One. 2015 Mar 25;10(3):e0121706. doi: 10.1371/journal.pone.0121706. eCollection 2015.

5.

MTA1 Expression in Benign and Malignant Salivary gland Tumors.

Andisheh-Tadbir A, Dehghani-Nazhvani A, Ashraf MJ, Khademi B, Mirhadi H, Torabi-Ardekani S.

Iran J Otorhinolaryngol. 2016 Jan;28(84):51-9.

6.

Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors.

Aoyama T, Takasawa A, Murata M, Osanai M, Takano K, Hasagawa T, Sawada N.

Med Mol Morphol. 2018 Jun 28. doi: 10.1007/s00795-018-0199-6. [Epub ahead of print]

PMID:
29955965
7.

Implications of methylation patterns of cancer genes in salivary gland tumors.

Williams MD, Chakravarti N, Kies MS, Maruya S, Myers JN, Haviland JC, Weber RS, Lotan R, El-Naggar AK.

Clin Cancer Res. 2006 Dec 15;12(24):7353-8.

8.

Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.

Rotellini M, Palomba A, Baroni G, Franchi A.

Appl Immunohistochem Mol Morphol. 2014 May-Jun;22(5):390-4. doi: 10.1097/PAI.0b013e3182936ea7.

PMID:
23958548
9.

Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.

Nikitakis NG, Scheper MA, Papanikolaou VS, Sklavounou A, Sauk JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jun;107(6):837-43. doi: 10.1016/j.tripleo.2008.12.052. Epub 2009 Mar 9.

10.

Salivary gland tumors at in vivo proton MR spectroscopy.

King AD, Yeung DK, Ahuja AT, Tse GM, Yuen HY, Wong KT, van Hasselt AC.

Radiology. 2005 Nov;237(2):563-9.

PMID:
16244265
11.

Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis.

Flores BC, Louren├žo SV, Damascena AS, Kowaslki LP, Soares FA, Coutinho-Camillo CM.

Virchows Arch. 2017 Mar;470(3):291-299. doi: 10.1007/s00428-016-2049-z. Epub 2016 Dec 15.

PMID:
27981346
12.

Caveolin-1 overexpression in benign and malignant salivary gland tumors.

Jaafari-Ashkavandi Z, Ashraf MJ, Nazhvani AD, Azizi Z.

Tumour Biol. 2016 Feb;37(2):1863-9. doi: 10.1007/s13277-015-3968-z. Epub 2015 Sep 1.

PMID:
26323261
13.

MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus.

Takahashi P, Xavier DJ, Evangelista AF, Manoel-Caetano FS, Macedo C, Collares CV, Foss-Freitas MC, Foss MC, Rassi DM, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Gene. 2014 Apr 15;539(2):213-23. doi: 10.1016/j.gene.2014.01.075. Epub 2014 Feb 11.

PMID:
24530307
14.

Immunoprofile of c-MET/PI3K signaling in human salivary gland tumors.

Vasconcelos AC, Wagner VP, Meurer L, Vargas PA, de Souza LB, Fonseca FP, Squarize CH, Castilho RM, Martins MD.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Aug;120(2):238-47. doi: 10.1016/j.oooo.2015.04.003. Epub 2015 Apr 24.

PMID:
26117810
15.

[Malignant salivary gland tumors. Effect of histology and site on prognosis].

Chilla R, Casjens R, Eysholdt U, Droese M.

HNO. 1983 Aug;31(8):286-90. German.

PMID:
6629867
16.

Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.

Maruya S, Shirasaki T, Nagaki T, Kakehata S, Kurotaki H, Mizukami H, Shinkawa H.

BMC Cancer. 2009 Feb 27;9:72. doi: 10.1186/1471-2407-9-72.

17.

DIANA-miRPath v3.0: deciphering microRNA function with experimental support.

Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG.

Nucleic Acids Res. 2015 Jul 1;43(W1):W460-6. doi: 10.1093/nar/gkv403. Epub 2015 May 14.

18.

GATA3 immunohistochemical expression in salivary gland neoplasms.

Schwartz LE, Begum S, Westra WH, Bishop JA.

Head Neck Pathol. 2013 Dec;7(4):311-5. doi: 10.1007/s12105-013-0442-3. Epub 2013 Apr 20.

19.

A review of 413 salivary gland tumours in the head and neck region.

Lawal AO, Adisa AO, Kolude B, Adeyemi BF, Olajide MA.

J Clin Exp Dent. 2013 Dec 1;5(5):e218-22. doi: 10.4317/jced.51143. eCollection 2013 Dec 1.

20.

Immunohistochemical expression of oestrogen receptor-╬▒ and progesterone receptor in salivary gland tumours.

Kolude B, Adisa A, Adeyemi B, Lawal A.

J Oral Pathol Med. 2013 Oct;42(9):716-9. doi: 10.1111/jop.12071. Epub 2013 Apr 19.

PMID:
23601083

Supplemental Content

Support Center